MENU
+Compare
CRL
Stock ticker: NYSE
AS OF
Jan 14, 04:59 PM (EDT)
Price
$216.32
Change
-$2.67 (-1.22%)
Capitalization
10.78B

CRL Charles River Laboratories International Forecast, Technical & Fundamental Analysis

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services... Show more

CRL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CRL with price predictions
Jan 13, 2026

CRL's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CRL turned positive on January 05, 2026. Looking at past instances where CRL's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRL advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 239 cases where CRL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRL broke above its upper Bollinger Band on January 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CRL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.165) is normal, around the industry mean (13.332). CRL has a moderately high P/E Ratio (577.050) as compared to the industry average of (127.018). CRL's Projected Growth (PEG Ratio) (0.161) is slightly lower than the industry average of (1.939). CRL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (2.734) is also within normal values, averaging (12.980).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
CRL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRL is expected to report earnings to fall 3.29% to $2.35 per share on February 18

Charles River Laboratories International CRL Stock Earnings Reports
Q4'25
Est.
$2.35
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.62
Q1'25
Beat
by $0.25
Q4'24
Beat
by $0.12
The last earnings report on November 05 showed earnings per share of $2.43, beating the estimate of $2.34. With 294.75K shares outstanding, the current market capitalization sits at 10.78B.
A.I. Advisor
published General Information

General Information

a provider of laboratory testing and research services on a contract basis

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
251 Ballardvale Street
Phone
+1 781 222-6000
Employees
21800
Web
https://www.criver.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BMEZ15.320.04
+0.26%
BlackRock Health Sciences Term Trust
PSQA20.430.01
+0.05%
Palmer Square CLO Senior Debt ETF
XFEB35.82-0.02
-0.06%
FT Vest US Eq Enh & Mod Buf ETF-Feb
LCTD56.25-0.25
-0.44%
iShares Wld ex USCrbTrnstnRdnssAwrActETF
DRGN36.45-1.31
-3.47%
Themes CHN Generative Artfcl Intlgc ETF

CRL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+0.08%
IQV - CRL
73%
Closely correlated
+0.29%
A - CRL
64%
Loosely correlated
-1.13%
RVTY - CRL
63%
Loosely correlated
+6.02%
MTD - CRL
63%
Loosely correlated
-0.48%
TMO - CRL
58%
Loosely correlated
-1.36%
More

Groups containing CRL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+0.08%
CRL
(2 stocks)
94%
Closely correlated
-0.66%